Insider Transactions in Q2 2025 at Johnson & Johnson (JNJ)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 01
2025
|
John C Reed EVP, Innovative Medicine, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
11,002
-26.97%
|
$1,716,312
$156.31 P/Share
|
|
May 01
2025
|
John C Reed EVP, Innovative Medicine, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
25,255
+38.24%
|
-
|